PSA value in blood Risk of finding prostate cancer at biopsy Less than 2.0 ng/ml 7.1% Between 2.0 and 3.9 ng/ml 18.7% Between 4.0 and 5.9 ng/ml 21.3% Between 6.0 and 7.9 ng/ml 28.6% Between 8.0 and 9.9 ng/ml 31.7% 10.0 ng/ml or more 56.5% Based on biopsies from 2267 men who...
51%, respectively; overall p=0.013.Conclusions:In biopsy-nave men with mild PSA elevations, use of our risk calculator resulted in a biopsy population that had more high-grade cancer and fewer negative biopsies compared to a historical group. Only family history and higher predicted cancer risks...
[16]Chen R, Xie L, Xue W, et al. Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy. Urol Oncol. 2016; 34(9): 416. e1,416. e7. [17]Niu X, Li J, Das SK, Xiong Y, Yang C, Peng T. Devel...
To determine the density of PSA, you will need your PSA result and the volume of your prostate or its dimensions. Do not hesitate to check out our other health calculators, including the body fat calculator and the lung cancer risk calculator. We try our best to make our Omni Calculators ...
11. Ren S, Xu J, Zhou T, Jiang H, Chen Het al.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.The Prostate2013;73: 1824-35. 12. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MSet al.Prevalence of prostate cancer among men with...
[3]Salagierski M,Schalken JA.Molecular diagnosis of prostate cancer:PCA3 and TMPRSS2:ERG gene fusion[J].J Urol,2012,187(3):795-801. [4]Ankerst DP,Boeck A,Freedland SJ,et al.Evaluating the PCPT risk calculator in ten international biopsy cohorts:results from the Prostate Biopsy Collabora...
Compliance with biopsy recommendations of a prostate cancer risk calculator Study Type - Diagnostic (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? So far, few publications have shown that a ... HAV Vugt,MJ Roobol,M Busstra,... - 《Bju Internati...
Reports that prostate specific antigen (PSA) doubling time seems to be a predictor of the probability of distant metastasis and prostate-cancer specific survival in men with biochemical relapse after radical prostatectomy, according to a study conducted by researchers from Baltimore, Maryland. Highlights...
Prostate specific antigen (PSA/KLK3) is known to be the chief executor of the fragmentation of semenogelins, dissolution of semen coagulum, thereby releasing sperm for active motility. Recent research has found that semenogelins also play significant roles in sperm fertility by affecting hyaluronidas...
1217 THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND THE RELATIONSHIP BETWEEN PSA AND BIOPSY OUTCOMEdoi:10.1016/j.juro.2012.02.1506Vickers, A.J.Sjoberg, D.Ankerst, D.P.Tangen, C.M.Goodman, P.J.Thompson, I.M.Journal of Urology...